Evaluation of a preventive program to reduce sensitization at a beryllium metal, oxide, and alloy production plant

Journal of Occupational and Environmental Medicine

Volumn 52, Issue 5, 2010, Pages 505-512

  Bailey, Rachel L ^a   Thomas, Carrie A ^a   Deubner, David C ^b   Kent, Micael S ^b   Kreiss, Kathleen ^a   Schuler, Christine R ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b Brush Wellman Inc North America   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOY; BERYLLIUM; OXIDE;

ADULT; ARTICLE; CHEMICAL INDUSTRY; CONTROLLED STUDY; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INCIDENCE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL HEALTH; PREVALENCE; PRIMARY PREVENTION; SENSITIZATION; WORKPLACE;

EID: 77952297623     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3181d6c338     Document Type: Article

References (17)

1. Kreiss K, Newman LS, Mroz MM, Campbell PA. Screening blood test identifies subclinical beryllium disease. J Occup Med. 1989;31:603-608.
2. Henneberger PK, Cumro D, Deubner DD, Kent MS, McCawley M, Kreiss K. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Int Arch Occup Environ Health. 2001;74:167-176.
3. Cummings KJ, Deubner DC, Day GA, et al. Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers. Occup Environ Med. 2007;64:134-140.
4. Thomas CA, Bailey RL, Deubner DC, Kreiss K, Schuler CR. Preventive program reduces beryllium sensitization among new employees at a copperberyllium alloy facility. Public Health Rep. 2009; 124 (Suppl 1) : 112-124.
5. Kreiss K, Mroz MM, Zhen B, Wiedemann H, Barna B. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup Eniron Med. 1997;54:605-612.
6. Schuler CR, Deubner DC, Day GA, Henneberger PK, Kreiss K. Risk of beryllium disease among short-term and long-term workers at a metal, oxide, and alloy production plant. Am J Respir Crit Care Med. 2003;167:A680.
7. Deubner D, Kent M. Keeping beryllium workers safe: an enhanced preventive model. J Occup Environ Hyg. 2007;4:D23-D30.
8. Newman LS, Mroz MM, Maier LA, Daniloff EM, Balkissoon, R. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant. J Occup Eniron Med. 2001;43:231-237.
9. Schuler CR, Kent MS, Deubner DC, et al. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility. Am J Ind Med. 2005;47:195-205.
10. Frome EL, Newman LS, Cragle DL, Colyer SP, Wambach PF. Identification of an abnormal beryllium lymphocyte proliferation test. Toxicology. 2003;183:39-56.
11. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods. Belmont, CA: Wadsworth, Inc; 1982:299.
12. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers; 1998.
13. Curtis GH. Cutaneous hypersensitivity due to beryllium; a study of thirteen cases. AMA Arch Derm Syphilol. 1951;64:470-482.
14. Deubner D, Kelsh M, Shum M, Maier L, Kent M, Lau E. Beryllium sensitization, chronic beryllium blood lymphocyte proliferation test (BLPT) : preliminary analysis of the ongoing workforce survey. Appl Occup Environ Hyg. 2001;16:521-526.
15. Stange AW, Furman FJ, Hilmas DE. The beryllium lymphocyte proliferation test: relevant issues in beryllium health surveillance. Am J Ind Med. 2004;46:453-462.
16. 3. Am J Ind Med. 1996;30:16-25.
17. Schuler CR, Kitt MM, Henneberger PK, Deubner DC, Kreiss K. Cumulative sensitization and disease in a beryllium oxide ceramics worker cohort. J Occup Environ Med. 2008;50:1343-1350.